The pilot testing of the RESIL-Card tool, launched in April 2025 with ten hospitals in Spain and Italy, is now complete. Led by CatSalut, the study evaluated usability, applicability, and challenges through real-life implementation. Findings will inform improvements of the tool ahead of its 2026 rollout.

Feedback from users who took part in the pilot testing of the RESIL-Card tool is being analysed and will be used to develop the final version for dissemination. In the meantime, let's take a look at some initial insights and impressions gathered from the pilot participants’ experience.

As the RESIL-Card pilot phase concludes, Europe-wide dissemination is being planned for 2026. The consortium will actively engage with the cardiovascular community, patients, and policymakers to drive broad adoption and integration of the tool into EU healthcare systems.

GISE is the Italian society of interventional cardiology, leading scientific development, supporting professionals, and strengthening patient care. By helping to tailor the RESIL-Card tool to the realities of frontline work and driving national communication and dissemination, GISE is positioning Italy as a model for adopting crisis-ready cardiovascular care.